Menu
Back to User profile » Prof. Dr. Nikolaus Kneidinger
Papers published by Prof. Dr. Nikolaus Kneidinger:
Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis
Mümmler C, Mertsch P, Barnikel M, Haubner F, Schönermarck U, Grabmaier U, Schulze-Koops H, Behr J, Kneidinger N, Milger K
Journal of Asthma and Allergy 2024, 17:557-572
Published Date: 6 June 2024
Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
Barnikel M, Grabmaier U, Mertsch P, Ceelen F, Janke C, Behr J, Kneidinger N, Milger K
Journal of Asthma and Allergy 2023, 16:1229-1232
Published Date: 9 November 2023
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
Kayser MZ, Drick N, Milger K, Fuge J, Kneidinger N, Korn S, Buhl R, Behr J, Welte T, Suhling H
Journal of Asthma and Allergy 2021, 14:863-871
Published Date: 12 July 2021
Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H
Journal of Asthma and Allergy 2020, 13:605-614
Published Date: 11 November 2020
Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism
Milger K, Holdt LM, Teupser D, Huber RM, Behr J, Kneidinger N
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:891-897
Published Date: 7 May 2015